Search

1,800 Seconds™ in Vaccines and MS Treatment

Release Date: October 7, 2021 Valid for Credit Through: October 7, 2022 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. Supported by an independent educational grant from Biogen. Credit Available Physicians— maximum of 0.5 AMA PRA Category 1 Credit(s)™ Nurses— maximum of 0.5 contact hours of nursing continuing professional …

IJMSC: Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic

Release Date: October 1, 2021 Valid for Credit Through: October 1, 2022 Evaluation of Treatment Practices for Urinalyses and Urine Cultures at an Outpatient Multiple Sclerosis Clinic Nicole C. Griffith, PharmD; Brandon K. Hill, PharmD; Myla D. Goldman, MD; S. Ross Tingen, PharmD Target Audience: The target audience for this activity is physicians, physician assistants, …

Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Released: August 27, 2021 Expiration: August 26, 2022 Learning Objectives Upon completion of this activity, participants should be able to: Adopt best practices in recognizing and managing comorbidities in patients with MS Discuss the influence of comorbidities on MS treatment …

Medical Minute: Influence of Anxiety and Depression on MS and Associated Symptoms

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Released: August 26, 2021 Expiration: August 25, 2022 Learning Objectives Upon completion of this activity, participants should be able to: Adopt best practices in recognizing and managing comorbidities in patients with MS Discuss the influence of comorbidities on MS treatment …

The Importance of Managing Fatigue in Multiple Sclerosis

Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Released: August 26, 2021 Expiration: August 25, 2022 Learning Objectives Upon completion of this activity, participants should be able to: Adopt best practices in recognizing and managing comorbidities in patients with MS Target Audience This program is intended for neurologists, …

Managing MS: A Team Approach – Broadcast Series

Patients with multiple sclerosis require care from a comprehensive network of providers, from neurologists to physical therapists, psychiatrists, and speech therapists. Join Patricia Bobryk, MHS, PT, MSCS, ATP, for a weekly broadcast series, where she speaks with experts in these fields to gain insight on and review the clinical issues faced by patients with MS. …

5-Part Podcast Series: Recent Clinical Updates in the Management of Multiple Sclerosis

Earn 1.25 AMA PRA Category 1 Credit(s)™, 1.25 contact hours for nursing professionals, 1.25 contact hours (.1 CEUs) for pharmacists, or 1.25 AAPA Category 1 CME credits The rapidly expanding range of disease modifying therapies (DMTs) has changed the clinical approach to the management of patients with multiple sclerosis (MS). The emergence of numerous therapeutic options …

IJMSC: Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research

Release Date: August 1, 2021 Valid for Credit Through: August 1, 2022 Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research Tracy E. Herring, PhD; Lindsey M. Knowles, PhD; Kevin N. Alschuler, PhD Target Audience: The target audience for this activity is physicians, physician assistants, nursing professionals, rehabilitation professionals, …

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022 Activity Overview This Clinical Consultations™ is a video-based program in which two experts discuss the management of patients with multiple sclerosis (MS) and SARS-CoV-2 vaccinations. In this activity, the faculty focus on the effects of disease modifying therapies (DMTs) on vaccine practices, specifically the mRNA …